NZ To Replace 'Outdated And Piecemeal' Device Rules
Executive Summary
There are significant changes in store for New Zealand’s medical device sector, including a new regulator and a set of pre- and post-market regulatory controls.
You may also be interested in...
Australia Consults On Which EU Definitions To Align With And Which To Ignore
Australia's Therapeutic Goods Administration also wants to extend the scope of the products it regulates as medical devices to include the non-medical-use products now captured in the new EU Medical Device Regulation.
EMA Probe Finds No Link Between GLP-1s And Suicidal Thoughts & Actions
After reviewing the evidence from non-clinical studies, clinical trials, post-marketing surveillance data and other studies, the European Medicines Agency said there was no need to update the product information for 11 diabetes and weight management drugs.
English Funding For Aquipta Targets AbbVie’s Migraine Drug To 170,000 People
Aquipta is the first oral treatment that NICE has recommended for preventing chronic migraines in the fourth-line setting, and the second oral treatment for episodic migraines in the same setting. The drug has already secured reimbursement in Scotland, Sweden and Israel.